Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children

scientific article

Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBMT.2009.08.001
P698PubMed publication ID19896081
P5875ResearchGate publication ID38073348

P50authorFelix ZintlQ15453728
Klaus-Michael DebatinQ18022197
Bernd GruhnQ89749384
Daniel SteinbachQ110990457
P2093author name stringRoland Zell
James F Beck
Selim Corbacioglu
Nadine Pfaffendorf
Juliane Intek
P433issue12
P304page(s)1571-1577
P577publication date2009-10-01
P1433published inBiology of Blood and Marrow TransplantationQ15754328
P1476titlePolymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children
P478volume15

Reverse relations

cites work (P2860)
Q90374351A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms
Q27021123Advances in predicting acute GVHD
Q54636018Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population.
Q28248522Association between NOD2 single nucleotide polymorphisms and Grade III-IV acute graft-versus-host disease: A meta-analysis
Q28075204Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives
Q35224947Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.
Q27026616Evaluation of published single nucleotide polymorphisms associated with acute GVHD
Q39263959From genetic single candidate gene studies to complex genomics of GvHD.
Q37810124Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation.
Q26824540Graft-versus-host disease biomarkers: omics and personalized medicine
Q38539817IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.
Q35564082Impact of inflammatory cytokine gene polymorphisms on developing acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation.
Q35084400Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD
Q33839876Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation
Q38057238NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome
Q38502469Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?
Q38132090Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses
Q37887810Role of gut microbiota in graft-versus-host disease
Q38129337Role of non-HLA gene polymorphisms in graft-versus-host disease.
Q37973866The IL-17 differentiation pathway and its role in transplant outcome
Q84561203Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors
Q38712496Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease

Search more.